Matrifen® with advanced matrix fentanyl patch technology eases your pain

Matrifen® from Nycomed with advanced matrix fentanyl patch technology provides excelent pain relief for patients with severe chronic pain.

Matrifen® with advanced matrix fentanyl patch technology is a transdermal patch wich provides relief for patients with severe chronic pain.

>> Information on Matrifen® with advanced matrix fentanyl patch technology

Matrifen® is a transdermal patch with with advanced matrix fentanyl patch technology. It is a 72 hour or 3 day patch with a skin friendly silicone adhesion layer, that sticks well to the surface of the skin.

The efficient and advanced matrix fentanyl patch technology provides pain relief for cancer related as well as non cancer related pains and the lower drug load adds to a higher degree of safety and lower environmental burden.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Treatment of non cancer pain | Fentanyl patch | 72 hour fentanyl release